Gałasiński W
Department of General and Organic Chemistry, Institute of Chemistry, Medical Academy, Białystok, Poland.
Proc Soc Exp Biol Med. 1996 May;212(1):24-37. doi: 10.3181/00379727-212-43988.
The structural and functional characteristics of the elongation system (ribosomes and elongation factors) are presented. The immunochemical and diagnostic meaning of the ribosome investigations is considered. Evidence of the participation of ribosomes in the first step of protein glycosylation is presented. The heterogeneous elongation factor eEF-1, isolated from Guerin epithelioma, can be separated into three fractions: one of them functionally corresponds to EF-1 alpha, the second on to EF-1 beta gamma, and the third is an unidentified, active aggregate named EF-1B, which contains the subunit forms EF-1 alpha and EF-1 beta gamma, and other polypeptides showing protein kinase activity. The aggregate EF-1B can be autophosphorylated, while the subunit forms EF-1 alpha and EF-1 beta gamma can neither become autophosphorylated nor phosphorylate other polypeptides. The subunit form EF-beta gamma consists from two polypeptides of 32 and 51 kDa, corresponding to other eukaryotic beta and gamma polypeptides, respectively. EF-1 beta gamma is thermostable and protects against thermal inactivation of EF-1 alpha in the EF-1 alpha-EF-1 beta gamma complex. Pure eEF-2 preparations isolated from normal and neoplastic tissues show different structural features. The existence of eEF-2 in multiple forms, differing in molecular mass, have been found. The eEF-2 with molecular weight of about 100 kDa can be phosphorylated, while eEF-2 of about 65 kDa was not phosphorylated by protein kinase eEF-2. The phosphorylated eEF-2 lost its activity, and this effect was reversed by dephosphorylation. The eEF-2 (65 kDa) was isolated from the active polyribosomes, and it may directly participate in the translocation step of the peptide elongation. It was noted that the components of elongation system can be inhibited, in separate steps, by the substances isolated from various sources of plant origin. Alkaloids emetine and cepheline, cardiac remedy digoxin, saponin glycoside, and its aglycon directly inactivated ribosomes. Quercetin inhibited eEF-1 activity by directly influencing its subunit form EF-1 alpha. eEF-2 was shown to be a target site of the inhibitory action of the glycoside isolated from Melissa officinalis leaves.
本文介绍了延伸系统(核糖体和延伸因子)的结构和功能特征。探讨了核糖体研究的免疫化学及诊断意义。提供了核糖体参与蛋白质糖基化第一步的证据。从格林氏上皮瘤中分离出的异质性延伸因子eEF - 1可分为三个部分:其中一个在功能上对应于EF - 1α,第二个对应于EF - 1βγ,第三个是一种未鉴定的活性聚集体,称为EF - 1B,它包含亚基形式的EF - 1α和EF - 1βγ以及其他具有蛋白激酶活性的多肽。聚集体EF - 1B可进行自身磷酸化,而亚基形式的EF - 1α和EF - 1βγ既不能进行自身磷酸化,也不能使其他多肽磷酸化。亚基形式的EF - βγ由两条分别为32 kDa和51 kDa的多肽组成,分别对应于其他真核生物的β和γ多肽。EF - 1βγ具有热稳定性,可保护EF - 1α - EF - 1βγ复合物中的EF - 1α免受热失活影响。从正常组织和肿瘤组织中分离出的纯eEF - 2制剂显示出不同的结构特征。已发现存在多种分子量不同的eEF - 2形式。分子量约为100 kDa的eEF - 2可被磷酸化,而约65 kDa的eEF - 2不能被蛋白激酶eEF - 2磷酸化。磷酸化的eEF - 2失去活性,去磷酸化可使其恢复活性。从活性多核糖体中分离出了eEF - 2(65 kDa),它可能直接参与肽链延伸的转位步骤。值得注意的是,延伸系统的组分在不同步骤可被从各种植物来源分离出的物质所抑制。生物碱吐根碱和头孢碱、强心药地高辛、皂苷糖苷及其苷元可直接使核糖体失活。槲皮素通过直接影响其亚基形式的EF - 1α来抑制eEF - 1活性。已证明eEF - 2是从蜜蜂花叶片中分离出的糖苷抑制作用的靶点。